Lexington, MA, United States of America

Punit Upadhyaya

USPTO Granted Patents = 10 

Average Co-Inventor Count = 4.5

ph-index = 5

Forward Citations = 75(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of Punit Upadhyaya

Introduction

Punit Upadhyaya is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of peptide complexes, holding a total of 10 patents. His work focuses on innovative solutions for cancer treatment and other medical applications.

Latest Patents

One of his latest patents is the "Heterotandem bicyclic peptide complex." This invention relates to a heterotandem bicyclic peptide complex that includes a first peptide ligand binding to Nectin-4, conjugated via a linker to two second peptide ligands that bind to CD137. The invention aims to prevent, suppress, or treat cancer. Another significant patent is the "Multimeric bicyclic peptide ligands." This invention describes multimers of polypeptides covalently bound to molecular scaffolds, allowing for the creation of high-affinity binders and activators of CD137. It also includes drug conjugates comprising these peptides, which can be used in treating diseases mediated by CD137.

Career Highlights

Punit Upadhyaya has worked with companies such as Bicycletx Limited and Bicyclerd Limited. His experience in these organizations has contributed to his expertise in peptide technology and drug development.

Collaborations

He has collaborated with notable individuals in his field, including Kevin McDonnell and Gemma Elizabeth Mudd. These partnerships have further enhanced his innovative work in peptide research.

Conclusion

Punit Upadhyaya's contributions to the field of peptide complexes and cancer treatment demonstrate his commitment to innovation and research. His patents reflect a deep understanding of biochemistry and a dedication to improving medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…